化学抗原受体T细胞免疫疗法用于妇科恶性瘤
Yajuan Gao1, Jing He2, Jing Wang1
1Department of Gynecology and Obstetrics, Hangzhou Women's Hospital (Hangzhou Maternity and Child Health Care Hospital), Hangzhou, Zhejiang 310008, China.
Critical reviews in oncology/hematology
|March 2, 2025
概括
化学抗原受体 (CAR) T细胞疗法对妇科恶性瘤有希望,但其在固体瘤中的有效性需要进一步调查. 本综述探讨了CAR T细胞的应用,挑战和妇科癌症的策略.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 细胞疗法 细胞疗法
背景情况:
- 妇科恶性瘤是一个重大的全球健康问题.
- 目前对晚期或复发性妇科癌症的治疗方法仍然有限.
- 化学抗原受体 (CAR) T细胞疗法已经改变了血液癌症治疗.
研究的目的:
- 审查针对妇科癌症抗原的CAR T细胞工程和机制.
- 评估CAR T细胞治疗妇科瘤的当前临床应用和试验进展.
- 讨论在这个领域推进CAR T细胞治疗的挑战和战略.
主要方法:
- 对针对妇科恶性瘤的CAR-T细胞治疗现有文献的系统审查.
- 分析针对特定妇科癌症抗原的CAR T细胞机制.
- 评估当前临床试验数据和未来研究方向.
主要成果:
- 卡尔T细胞疗法已在血液癌症中取得成功,对固体瘤的兴趣日益增加.
- 在妇科恶性瘤中CAR T细胞疗法的有效性需要进一步验证.
- 特定的抗原和工程策略对于CAR T细胞在妇科癌症中的疗效至关重要.
结论:
- 卡尔T细胞疗法具有治疗妇科恶性瘤的潜力.
- 需要进一步的研究和临床试验来克服挑战并优化疗效.
- 本综述为未来在妇科瘤学中使用CAR T细胞治疗的发展提供了基础.
相关概念视频
01:27Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K